Furthermore, survival analysis showed that high expression of TRPV3 was associated with poor prognosis of ccRCC patients, whereas high expression of TRPV4 conferred a favorable prognosis. This evidence concerns the gene TRPV4 and nonpapillary renal cell carcinoma.